Gene dosage effects and transcriptional regulation of early mammalian adrenal cortex development

Molecular and Cellular Endocrinology

Volumn 323, Issue 1, 2010, Pages 105-114

  Val, Pierre ^a   Swain, Amanda ^b  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; FETAL ADRENAL ENHANCER PROTEIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 2; NUCLEAR RECEPTOR DAX 1; ODD SKIPPED RELATED 1 PROTEIN; PROTEIN CITED2; PROTEIN SF 1; SONIC HEDGEHOG PROTEIN; STEROIDOGENIC FACTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOX; TRANSCRIPTION FACTOR M33; TRANSCRIPTION FACTOR PBX1; TRANSCRIPTION FACTOR POD1; UNCLASSIFIED DRUG; WNT PROTEIN; WT1 PROTEIN;

ADRENAL CORTEX; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; HETEROZYGOSITY; HOMOZYGOSITY; MAMMAL; NONHUMAN; ORGANOGENESIS; PRIMORDIUM; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADRENAL CORTEX; ANIMALS; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, WILMS TUMOR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 77952886784     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.12.010     Document Type: Review

References (121)

1. Achermann J.C., et al. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat. Genet. 1999, 22(2):125-126.
2. Achermann J.C., Meeks J.J., Jameson J.L. Phenotypic spectrum of mutations in DAX-1 and SF-1. Mol. Cell. Endocrinol. 2001, 185(1-2):17-25.
3. Achermann J.C., et al. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J. Clin. Endocrinol. Metab. 2002, 87(4):1829-1833.
4. Alvarez-Medina R., et al. Wnt canonical pathway restricts graded Shh/Gli patterning activity through the regulation of Gli3 expression. Development 2008, 135(2):237-247.
5. Babu P.S., et al. Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1. Endocrinology 2002, 143(2):665-673.
6. Bamforth S.D., et al. Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nat. Genet. 2001, 29(4):469-474.
7. Bamforth S.D., et al. Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway. Nat. Genet. 2004, 36(11):1189-1196.
8. Basile D.P., Holzwarth M.A. Basic fibroblast growth factor may mediate proliferation in the compensatory adrenal growth response. Am. J. Physiol. 1993, 265(6 Pt 2):R1253-R1261.
9. Basile D.P., Holzwarth M.A. Basic fibroblast growth factor receptor in the rat adrenal cortex: effects of suramin and unilateral adrenalectomy on receptor numbers. Endocrinology 1994, 134(6):2482-2489.
10. Beuschlein F., et al. Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy. Endocrinology 2002, 143(8):3122-3135.
11. Bhattacharya S., et al. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 1999, 13:64-75.
12. Birk O.S., et al. The LIM homeobox gene Lhx9 is essential for mouse gonad formation. Nature 2000, 403(6772):909-913.
13. Bitgood M.J., McMahon A.P. Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev. Biol. 1995, 172(1):126-138.
14. Bland M.L., et al. Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(26):14488-14493.
15. Bland M.L., et al. Gene dosage effects of steroidogenic factor 1 (SF-1) in adrenal development and the stress. Endocr. Res. 2000, 26(4):515-516.
16. Bland M.L., Fowkes R.C., Ingraham H.A. Differential requirement for steroidogenic factor-1 gene dosage in adrenal development versus endocrine function. Mol. Endocrinol. 2004, 18(4):941-952.
17. Bose J., Grotewold L., Ruther U. Pallister-Hall syndrome phenotype in mice mutant for Gli3. Hum. Mol. Genet. 2002, 11(9):1129-1135.
18. Botrugno O.A., et al. Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Mol. Cell 2004, 15(4):499-509.
19. Bragança J., et al. Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and Cited-2. J. Biol. Chem. 2003, 278(18):16021-16029.
20. Buaas F.W., Val P., Swain A. The transcription co-factor CITED2 functions during sex determination and early gonad development. Hum. Mol. Genet. 2009, 18(16):2989-3001.
21. Challis B.G., et al. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). Proc. Natl. Acad. Sci. U.S.A. 2004, 101(13):4695-4700.
22. Chassot A.A., et al. Activation of beta-catenin signaling by Rspo1 controls differentiation of the mammalian ovary. Hum. Mol. Genet. 2008, 17(9):1264-1277.
23. Ching S., Vilain E. Targeted disruption of Sonic Hedgehog in the mouse adrenal leads to adrenocortical hypoplasia. Genesis 2009, 47(9):628-637.
24. Coll A.P., et al. The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin. Endocrinology 2004, 145(10):4721-4727.
25. Colvin J.S., et al. Male-to-female sex reversal in mice lacking fibroblast growth factor 9. Cell 2001, 104:875-889.
26. Cotton L.M., O'Bryan M.K., Hinton B.T. Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction. Endocr. Rev. 2008, 29(2):193-216.
27. Coutant R., et al. Heterozygous mutation of steroidogenic factor-1 in 46. XY subjects may mimic partial androgen insensitivity syndrome. J. Clin. Endocrinol. Metab. 2007, 92(8):2868-2873.
28. Crawford P.A., Sadovsky Y., Milbrandt J. Nuclear receptor steroidogenic factor 1 directs embryonic stem cells toward the steroidogenic lineage. Mol. Cell. Biol. 1997, 17(7):3997-4006.
29. Cui S., et al. Disrupted gonadogenesis and male-to-female sex reversal in Pod1 knockout mice. Development 2004, 131:4095-4105.
30. DiGiammarino E.L., et al. A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer. Nat. Struct. Biol. 2001, 9(1):12-16.
31. Doghman M., et al. Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol. Endocrinol. 2007, 21(12):2968-2987.
32. Doghman M., et al. Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors. J. Clin. Endocrinol. Metab. 2007, 92(8):3253-3260.
33. Else T., Hammer G.D. Genetic analysis of adrenal absence: agenesis and aplasia. Trends Endocrinol. Metab. 2005, 16(10):458-468.
34. Fatchiyah, et al. Differential gene dosage effects of Ad4BP/SF-1 on target tissue development. Biochem. Biophys. Res. Commun. 2006, 341(4):1036-1045.
35. Fayard E., Auwerx J., Schoonjans K. LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell. Biol. 2004, 14(5):250-260.
36. Figueiredo B.C., et al. Amplification of the steroidogenic factor 1 (SF-1) gene in childhood adrenocortical tumors. J. Clin. Endocrinol. Metab. 2005, 90(2):615-619.
37. Fuerer C., Nusse R., Ten Berge D. Wnt signalling in development and disease. Max Delbruck Center for Molecular Medicine Meeting on Wnt signaling in Development and Disease. EMBO Rep. 2008, 9(2):134-138.
38. Gaujoux S., et al. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors. J. Clin. Endocrinol. Metab. 2008, 93(10):4135-4140.
39. Gondo S., et al. Adipose tissue-derived and bone marrow-derived mesenchymal cells develop into different lineage of steroidogenic cells by forced expression of steroidogenic factor 1. Endocrinology 2008, 149(9):4717-4725.
40. Grigoryan T., et al. Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev. 2008, 22(17):2308-2341.
41. Gummow B.M., Winnay J.N., Hammer G.D. Convergence of Wnt signaling and steroidogenic factor-1 (SF-1) on transcription of the rat inhibin alpha gene. J. Biol. Chem. 2003, 278(29):26572-26579.
42. Hall J.G., et al. Congenital hypothalamic hamartoblastoma, hypopituitarism, imperforate anus and postaxial polydactyly-a new syndrome? Clinical, causal, and pathogenetic considerations. Am. J. Med. Genet. 1980, 7(1):47-74.
43. Hammes A., et al. Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation. Cell 2001, 106(3):319-329.
44. Hasegawa T., et al. Testicular dysgensis without adrenal insufficiency in a 46. XY patient with a heterozygous inactivae mutation of steroidogenic factor-1. J. Clin. Endocrinol. Metab. 2004, 89(12):5930-5935.
45. Hastie N.D. Life, sex, and WT1 isoforms-three amino acids can make all the difference. Cell 2001, 106(4):391-394.
46. Hatano O., et al. Identical origin of adrenal cortex and gonad revealed by expression profiles of Ad4BP/SF-1. Genes Cells 1996, 1(7):663-671.
47. Heikkila M., et al. Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology 2002, 143(11):4358-4365.
48. Hershkovitz L., et al. Adrenal 20alpha-hydroxysteroid dehydrogenase in the mouse catabolizes progesterone and 11-deoxycorticosterone and is restricted to the X-zone. Endocrinology 2007, 148(3):976-988.
49. Holzwarth M.A. Evidence for fibroblast growth factor mediation of compensatory adrenocortical proliferation. Endocr. Res. 1995, 21(1-2):115-119.
50. Hu L., et al. Expression of Cyp21a1 and Cyp11b1 in the fetal mouse testis. Reproduction 2007, 134(4):585-591.
51. Ikeda Y., et al. Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol. Endocrinol. 1994, 8(5):654-662.
52. Ikeda Y., et al. Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development. Mol. Endocrinol. 1996, 10(10):1261-1272.
53. Ishimoto H., et al. The periphery of the human fetal adrenal gland is a site of angiogenesis: zonal differential expression and regulation of angiogenic factors. J. Clin. Endocrinol. Metab. 2008, 93(6):2402-2408.
54. Iyer A.K., McCabe E.R. Molecular mechanisms of Dax1 action. Mol. Genet. Metab. 2004, 83(1-2):60-73.
55. Jeays-Ward C., et al. Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. Development 2003, 130(16):3663-3670.
56. Jordan B.K., et al. Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/β-catenin synergy. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(19):10866-10871.
57. Kang S., et al. GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat. Genet. 1997, 15(3):266-268.
58. Katoh M. WNT signaling pathway and stem cell signaling network. Clin. Cancer Res. 2007, 13(14):4042-4045.
59. Katoh Y., Katoh M. Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA. Int. J. Mol. Med. 2008, 22(3):271-275. (review).
60. Katoh-Fukui Y., et al. Male-to-female sex reversal in M33 mutant mice. Nature 1998, 393:688-692.
61. Katoh-Fukui Y., et al. Mouse Polycomb M33 is required for splenic vascular and adrenal gland formation through regulating Ad4BP/SF1 expression. Blood 2005, 106(5):1612-1620.
62. Keegan C.E., Hammer G.D. Recent insights into organogenesis of the adrenal cortex. Trends Endocrinol. Metab. 2002, 13(5):200-208.
63. Kempna P., Fluck C.E. Adrenal gland development and defects. Best Pract. Res. Clin. Endocrinol. Metab. 2008, 22(1):77-93.
64. Kim A.C., Hammer G.D. Adrenocortical cells with stem/progenitor cell properties: recent advances. Mol. Cell. Endocrinol. 2007, 265-266:10-16.
65. Kim Y., et al. Fibroblast growth factor receptor 2 regulates proliferation and Sertoli differentiation during male sex determination. Proc. Natl. Acad. Sci. U.S.A. 2007, 104(42):16558-16563.
66. Kim A.C., et al. Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex. Development 2008, 135(15):2593-2602.
67. King P.J., Guasti L., Laufer E. Hedgehog signalling in endocrine development and disease. J. Endocrinol. 2008, 198(3):439-450.
68. King P., Paul A., Laufer E. Shh signalling regulates adrenocortical development and identifies progenitors of steroidogenic lineages. Proc. Natl. Acad. Sci. USA. 2009, 106(50):21185-21190.
69. Kohler B., et al. Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46. XY patients with severe underandrogenization but without adrenal insufficiency. Hum. Mutat. 2008, 29(1):59-64.
70. Kreidberg J.A., et al. WT-1 is required for early kidney development. Cell 1993, 74(4):679-691.
71. Lalli E., Sassone-Corsi P. DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Mol. Endocrinol. 2003, 17(8):1445-1453.
72. Lefrancois-Martinez A.M., et al. Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors. J. Clin. Endocrinol. Metab. 2004, 89(6):3010-3019.
73. Lichtenauer U.D., et al. Pre-B-cell transcription factor 1 and steroidogenic factor 1 synergistically regulate adrenocortical growth and steroidogenesis. Endocrinology 2007, 148(2):693-704.
74. Lin L., et al. Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46, XY disorders of sex development with normal adrenal function. J. Clin. Endocrinol. Metab. 2007, 92(3):991-999.
75. Liu C.F., et al. Sex-Specific Roles of {beta}-catenin in Mouse Gonadal Development. Hum. Mol. Genet. 2008.
76. Looyenga B.D., Hammer G.D. Origin and identity of adrenocortical tumors in inhibin knockout mice: implications for cellular plasticity in the adrenal cortex. Mol. Endocrinol. 2006, 20(11):2848-2863.
77. Looyenga B.D., Hammer G.D. Genetic removal of Smad3 from inhibin-null mice attenuates tumor progression by uncoupling extracellular mitogenic signals from the cell cycle machinery. Mol. Endocrinol. 2007, 21(10):2440-2457.
78. Luo X., Ikeda Y., Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994, 77(4):481-490.
79. Mallet D., et al. Gonadal Dysgenesis without adrenal insufficiency in a 46. XY patient heterozygous for the nonsense C16X mutation: a case of SF1 haploinsufficiency. J. Clin. Endocrinol. Metab. 2004, 89(10):4829-4832.
80. Mesiano S., Jaffe R.B. Developmental and functional biology of the primate fetal adrenal cortex. Endocr. Rev. 1997, 18(3):378-403.
81. Mesiano S., Jaffe R.B. Role of growth factors in the developmental regulation of the human fetal adrenal cortex. Steroids 1997, 62(1):62-72.
82. Miyamoto N., et al. Defects of urogenital development in mice lacking Emx2. Development 1997, 124(9):1653-1664.
83. Mizusaki H., et al. Dax-1 gene transcription is regulated by Wnt4 in the female developing gonad. Mol. Endocrinol. 2003, 23:p23.
84. Nachtigal M.W., et al. Wilm's tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 1998, 93(3):445-454.
85. Nomura M., et al. An E box element is required for the expression of the ad4bp gene, a mammalian homologue of ftz-f1 gene, which is essential for adrenal and gonadal development. J. Biol. Chem. 1995, 270(13):7453-7461.
86. Orth D.N., Kovacs N.J. The adrenal cortex. Text Book of Endocrinology 1998, 517-664. WB Saunders Company, Philadelphia. 9th ed. J. Wilson (Ed.).
87. O'Shaughnessy P.J., et al. Adrenocorticotropic hormone directly stimulates testosterone production by the fetal and neonatal mouse testis. Endocrinology 2003, 144(8):3279-3284.
88. Park S.Y., et al. Nuclear receptors Sf1 and Dax1 function cooperatively to mediate somatic cell differentiation during testis development. Development 2005, 132(10):2415-2423.
89. Parker K.L., et al. Steroidogenic factor 1: an essential mediator of endocrine development. Recent Prog. Horm. Res. 2002, 57:19-36.
90. Quaggin S.E., et al. The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 1999, 126(24):5771-5783.
91. Reddy J.C., Licht J.D. The WT1 Wilm's tumor suppressor gene: how much do we really know?. Biochim. Biophys. Acta 1996, 1287:1-28.
92. Reuter A.L., et al. A novel mutation in the accessory DNA-binding domain of human steroidogenic factor 1 causes XY gonadal dysgenesis without adrenal insufficiency. Eur. J. Endocrinol. 2007, 157(2):233-238.
93. Ribeiro R.C., et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(16):9330-9335.
94. Roop D., Toftgard R. Hedgehog in wnterland. Nat. Genet. 2008, 40(9):1040-1041.
95. Sadovsky Y., et al. Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc. Natl. Acad. Sci. U.S.A. 1995, 92(24):10939-10943.
96. Schmahl J., et al. Fgf9 induces proliferation and nuclear localization of FGFR2 in Sertoli precursors during male sex determination. Development 2004, 131:3627-3636.
97. Schnabel C.A., Selleri L., Cleary M.L. Pbx1 is essential for adrenal development and urogenital differentiation. Genesis 2003, 37(3):123-130.
98. Schoonjans K., et al. Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(6):2058-2062.
99. So P.L., Danielian P.S. Cloning and expression analysis of a mouse gene related to Drosophila odd-skipped. Mech. Dev. 1999, 84(1-2):157-160.
100. Stallings N.R., et al. Development of a transgenic green fluorescent protein lineage marker for steroidogenic factor 1. Endocr. Res. 2002, 28(4):497-504.
101. Swain A., et al. Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat. Genet. 1996, 12(4):404-409.
102. Tamura M., et al. Pod-1/capsulin shows a sex- and stage-dependent expression pattern in the mouse gonad development and represses expression of Ad4BP/SF-1. Mech. Dev. 2001, 102(1-2):135-144.
103. Tanaka T., et al. Steroidogenic factor 1/adrenal 4 binding protein transforms human bone marrow mesenchymal cells into steroidogenic cells. J. Mol. Endocrinol. 2007, 39(5):343-350.
104. Tien E.S., Davis J.W., Vandel Heuven P. Identification of the CBP/p300 interacting protein Cited2 as a PPARα coregulator. J. Biol. Chem. 2004, 279(23):24053-24063.
105. Tissier F., et al. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res. 2005, 65(17):7622-7627.
106. Val P., et al. SF-1 a key player in the development and differentiation of steroidogenic tissues. Nuclear Receptor 2003, 1(8).
107. Val P., Jeays-Ward C., Swain A. Identification of a novel population of adrenal-like cells in the mammalian testis. Dev. Biol. 2006, 299:250-256.
108. Val P., Martinez Barbera J.P., Swain A. Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage. Development 2007, 134(12):2349-2358.
109. Wang G.M., et al. Expression of 11-β hydroxylase in rat Leydig cells. Endocrinology 2002, 143(2):621-626.
110. Wang Q., et al. Odd-skipped related (Odd1) is an essential regulator of heart and urogenital development. Dev. Biol. 2005, 288:582-594.
111. Weninger W.J., et al. Cited2 is required both for heart morphogenesis and establishment of the left-right axis in mouse development. Development 2005, 132:1337-1348.
112. Wilhelm D., Englert C. The Wilm's tumor suppressor WT1 regulates early gonad development by activation of Sf1. Genes Dev. 2002, 16(14):1839-1851.
113. Xu B., et al. DAX-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor-1 in steroidogenesis. Mol. Cell. Biol. 2009.
114. Yao H.H., Whoriskey W., Capel B. Desert Hedgehog/patched 1 signaling specifies fetal Leydig cell fate in testis organogenesis. Genes Dev. 2002, 16(11):1433-1440.
115. Yaswen L., et al. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat. Med. 1999, 5(9):1066-1070.
116. Yin Z., et al. The essential role of Cited2, a negative regulator for HIF1-alpha, in heart development and neurulation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99(16):10488-10493.
117. Yu R.N., et al. Role of Ahch in gonadal development and gametogenesis. Nat. Genet. 1998, 20(4):353-357.
118. Zacchetti G., Duboule D., Zakany J. Hox gene function in vertebrate gut morphogenesis: the case of the caecum. Development 2007, 134(22):3967-3973.
119. Zakany J., Duboule D. The role of Hox genes during vertebrate limb development. Curr. Opin. Genet. Dev. 2007, 17(4):359-366.
120. Zubair M., et al. Two-step regulation of Ad4BP/SF-1 gene transcription during fetal adrenal development: initiation by a Hox-Pbx1-Prep1 complex and maintenance via autoregulation by Ad4BP/SF-1. Mol. Cell. Biol. 2006, 26(11):4111-4121.
121. Zubair M., Parker K.L., Morohashi K.I. Developmental links between the fetal and adult adrenal cortex revealed by lineage tracing. Mol. Cell. Biol. 2008, 28(23):7030-7040.